Riskpilot← Back to searchSign inGet full accessWendek Vård AB
ABActiveOrg 5591768030Blynäsvägen 38General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2025
SEK 339K
-10% vs 2024
EBITDA margin
20.3%
+1586% vs 2024
Equity ratio
54.0%
Financial strength
Net profit 2025
SEK 56K
+1784% vs 2024
| Revenue | SEK 339K | -10% |
| EBITDA | SEK 69K | +1586% |
| Net profit | SEK 56K | +1784% |
| Total assets | SEK 190K | +29% |
| Equity | SEK 103K | +120% |
| Employees | 0 | — |
Legal name
Wendek Vård AB
Org number
5591768030
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
25 oktober 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva förmedling, rekrytering, uthyrning av vårdpersonal samt därmed förenlig verksamhet. Utbildning, rådgivning, konsultation, dokumentation inom hälso- och sjukvård. Bedriva sluten- och öppen hälso- och sjukvård samt därmed förenlig verksamhet. Handla äga och förvalta, fastigheter, värdepapper, valutor samt därmed förenlig verksamhet.
Address
Blynäsvägen 38
Email
wendekvard@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 348 | 41 | 216 | 375 | 339 |
| Staff expenses | — | −69 | −42 | −310 | −259 |
| EBITDA | 131 | −36 | 161 | −5 | 69 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 131 | −36 | 161 | −5 | 69 |
| Net financials | — | −10 | −8 | 1 | 0 |
| Profit before tax | 131 | −46 | 153 | −3 | 69 |
| Tax | −28 | — | −22 | — | −14 |
| Net profit | 103 | −46 | 131 | −3 | 56 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 215 | 115 | 186 | 147 | 190 |
| Equity | 153 | 4 | 134 | 47 | 103 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 63 | 111 | 52 | 100 | 87 |
| Total debt | 63 | 111 | 52 | 100 | 87 |
EBITDA margin
20.3%
This company
15.8%
Market median
+28% vs market
20212025
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
54.5%
This company
18.4%
Market median
+196% vs market
20212025
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
20212025
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20212025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wendek Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Nathalie Rejdin | Deputy Board Member | 0 companies |
| Bo Jacob Wendels Ek | Board of Directors | 0 companies |